NCT00516464View on ClinicalTrials.gov

Evaluation of Ranibizumab in Proliferative Diabetic Retinopathy (PDR) Requiring Vitrectomy

PHASE3UnknownINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

August 31, 2007

Study Completion Date

August 31, 2008

Conditions

Proliferative Diabetic Retinopathy

Interventions

DRUG

Lucentis (ranibizumab)

Trial Locations (1)

66204

RECRUITING

Retina Associates, PA, Shawnee Mission

Sponsors

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

Genentech, Inc.

INDUSTRY

lead

Retina Associates, Kansas City

OTHER

NCT00516464 - Evaluation of Ranibizumab in Proliferative Diabetic Retinopathy (PDR) Requiring Vitrectomy | Biotech Hunter | Biotech Hunter